American Journal of Kidney Diseases

Papers
(The H4-Index of American Journal of Kidney Diseases is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update829
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States336
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease311
Update on Lupus Nephritis: Core Curriculum 2020226
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider175
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury165
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States149
Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria134
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine129
COVID-19 in Hemodialysis Patients: A Report of 5 Cases123
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States122
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics116
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?115
CKD in China: Evolving Spectrum and Public Health Implications115
Ciliopathies and the Kidney: A Review115
Peritoneal Dialysis–Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)112
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine108
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis107
NSAIDs in CKD: Are They Safe?102
IgA Nephropathy: Core Curriculum 202199
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients98
Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 202193
COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle92
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation87
Membranous Nephropathy: Core Curriculum 202187
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?86
CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden83
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis82
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force82
Plant-Based Diets for Kidney Disease: A Guide for Clinicians80
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma76
CKD Awareness Among US Adults by Future Risk of Kidney Failure75
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Met73
Kidney Infarction in Patients With COVID-1969
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study68
Alport Syndrome: Achieving Early Diagnosis and Treatment67
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee64
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study61
Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection61
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study59
COVID-19 Outbreak in an Urban Hemodialysis Unit59
The Promise of Tubule Biomarkers in Kidney Disease: A Review59
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States58
Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics58
Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France57
Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study56
Coffee Consumption and Kidney Function: A Mendelian Randomization Study56
Burden of Kidney Disease, Health-Related Quality of Life, and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program56
Clinical Application of Kidney Biomarkers in Cirrhosis56
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study52
The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)51
0.045367956161499